Correlation Between Medigen Biotechnology and Orient Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medigen Biotechnology and Orient Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medigen Biotechnology and Orient Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medigen Biotechnology and Orient Pharma Co, you can compare the effects of market volatilities on Medigen Biotechnology and Orient Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medigen Biotechnology with a short position of Orient Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medigen Biotechnology and Orient Pharma.

Diversification Opportunities for Medigen Biotechnology and Orient Pharma

-0.66
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Medigen and Orient is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Medigen Biotechnology and Orient Pharma Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orient Pharma and Medigen Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medigen Biotechnology are associated (or correlated) with Orient Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orient Pharma has no effect on the direction of Medigen Biotechnology i.e., Medigen Biotechnology and Orient Pharma go up and down completely randomly.

Pair Corralation between Medigen Biotechnology and Orient Pharma

Assuming the 90 days trading horizon Medigen Biotechnology is expected to under-perform the Orient Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Medigen Biotechnology is 2.46 times less risky than Orient Pharma. The stock trades about -0.17 of its potential returns per unit of risk. The Orient Pharma Co is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  3,610  in Orient Pharma Co on September 13, 2024 and sell it today you would earn a total of  105.00  from holding Orient Pharma Co or generate 2.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Medigen Biotechnology  vs.  Orient Pharma Co

 Performance 
       Timeline  
Medigen Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medigen Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Medigen Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Orient Pharma 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Orient Pharma Co are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Orient Pharma showed solid returns over the last few months and may actually be approaching a breakup point.

Medigen Biotechnology and Orient Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medigen Biotechnology and Orient Pharma

The main advantage of trading using opposite Medigen Biotechnology and Orient Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medigen Biotechnology position performs unexpectedly, Orient Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orient Pharma will offset losses from the drop in Orient Pharma's long position.
The idea behind Medigen Biotechnology and Orient Pharma Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges